Along similar lines, TAMs exhibit high levels of both HIF-α isoforms in response to hypoxia and, in consonance, myeloid-specific deletion of HIF1α [85] or HIF2α [86] has recently been correlated to reduced tumor growth and better outcome in breast cancer and colon carcinoma, respectively. The gene discussed is HIF1A; the disease is neoplasm.